Stock Based Compensation (Tables) |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2026 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Share-Based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Equity Incentive Plan Transactions | Transactions in connection with the Company’s Equity Incentive Plans during the nine months ended September 30, 2026 were as follows:
(1) Includes 30,923 grants of performance-based restricted stock units that satisfied the performance obligation and are therefore likely to vest and excludes 585,842 grants of performance-based restricted stock units that are not considered outstanding until such time that they become probable to vest. (2) Includes 30,923 vested grants of performance-based restricted stock units. (3)
Includes 79,755 grants of performance-based restricted stock units that satisfied the performance obligation and are therefore likely to vest and excludes 521,925 grants of performance-based restricted stock units that are not considered outstanding until such time that they become probable to vest. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||